A non-surgical embryo transfer (NSET) device for producing gene-modified mice

用于生产基因修饰小鼠的非手术胚胎移植(NSET)装置

基本信息

  • 批准号:
    8059092
  • 负责人:
  • 金额:
    $ 45.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-03 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The use of research animals in research has been essential to development of vaccines and study of most human diseases. Modern rodent research is increasingly powerful with the ability to manipulate the genomes of mice and rats such that they closely mimic complex human diseases such as Alzheimer's and artherosclerosis. Generating transgenic mice and rats, requires that embryos that are manipulated by researchers be transferred into recipient female mice where they can complete their development. Up to this point, these transfers have required surgical procedures in which the embryo is implanted into the uterus. Recently, a device has been developed that enables these embryo transfers to be performed without surgery which eliminates the post-operative recovery period thereby reducing pain of the animals. This proposal investigates and expands upon the utility of this embryo transfer device by establishing the optimal ages and mouse strains for embryo transfer (Aim 1), determining whether embryonic stem cells can be effectively and efficiently transferred with this device (Aim 2), determining whether the device is useful for artificial inseminations (Aim 3), directly visualizing the device in the uterus which may enable design improvements (Aim 4) and quantifying measures of stress relative to surgical procedures to support widespread adoption of this procedure in the research community (Aim 5). The primary project objective is to produce data that will prove the efficacy of this embryo transfer device and thereby enable researchers to replace surgical procedures with a non-surgical method that is equally effective. Proving that this non-surgical transfer method is effective under a range of conditions will expand its use over this range of applications and thereby maximize its impact in enabling researchers to refine and reduce the number of surgical procedures performed in mice. PUBLIC HEALTH RELEVANCE: Animal use in research is essential for biomedical research and with the developing abilities to genetically engineer mice for research; these animals are becoming even more important as they can be modified to mimic most human diseases. Genetic engineering of mice requires, as one of many other things, the ability to transfer embryos into mice where they complete their development. This project supports further development of a device that enables these embryo transfers to be performed without surgery and therefore greatly reduces the pain category that these research animals experience and thereby supports progress in biomedicine.
描述(由申请人提供):在研究中使用研究动物对于开发疫苗和研究大多数人类疾病至关重要。现代啮齿类动物研究越来越强大,有能力操纵小鼠和大鼠的基因组,使它们接近模拟复杂的人类疾病,如阿尔茨海默氏症和动脉硬化。培育转基因小鼠和大鼠需要将研究人员操纵的胚胎转移到雌性小鼠受体中,在那里它们可以完成发育。到目前为止,这些移植都需要将胚胎植入子宫的外科手术。最近,已经开发出一种装置,使这些胚胎移植无需手术即可进行,从而消除了术后恢复期,从而减少了动物的痛苦。本提案通过建立胚胎移植的最佳年龄和小鼠品系(Aim 1),确定胚胎干细胞是否可以有效和高效地使用该装置移植(Aim 2),确定该装置是否适用于人工授精(Aim 3),研究并扩展了该胚胎移植装置的实用性。直接观察子宫内的装置,这可能有助于设计改进(目标4),并量化与手术过程相关的压力测量,以支持该过程在研究界的广泛采用(目标5)。该项目的主要目标是产生数据来证明这种胚胎移植装置的有效性,从而使研究人员能够用一种同样有效的非手术方法取代外科手术。证明这种非手术移植方法在一系列条件下是有效的,将扩大其应用范围,从而最大限度地提高其影响,使研究人员能够改进和减少在小鼠身上进行的外科手术的数量。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nonsurgical embryo transfer device compared with surgery for embryo transfer in mice.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Angelika Fath-Goodin其他文献

Angelika Fath-Goodin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Angelika Fath-Goodin', 18)}}的其他基金

Novel fluorescent protein expression vector that simplifies the solubilization of membrane proteins
新型荧光蛋白表达载体,可简化膜蛋白的溶解
  • 批准号:
    9462412
  • 财政年份:
    2017
  • 资助金额:
    $ 45.95万
  • 项目类别:
Enhanced baculovirus vectors with higher titers and increased genome stability
具有更高效价和更高基因组稳定性的增强型杆状病毒载体
  • 批准号:
    8517949
  • 财政年份:
    2013
  • 资助金额:
    $ 45.95万
  • 项目类别:
Enhanced baculovirus vectors with higher titers and increased genome stability
具有更高滴度和更高基因组稳定性的增强型杆状病毒载体
  • 批准号:
    8976604
  • 财政年份:
    2013
  • 资助金额:
    $ 45.95万
  • 项目类别:
Biological Methods for Enhancing Wound Healing Properties
增强伤口愈合性能的生物学方法
  • 批准号:
    8455424
  • 财政年份:
    2013
  • 资助金额:
    $ 45.95万
  • 项目类别:
Use of a viral mucin-like protein to convert adherent cells to suspension culture
使用病毒粘蛋白样蛋白将贴壁细胞转化为悬浮培养物
  • 批准号:
    8121973
  • 财政年份:
    2011
  • 资助金额:
    $ 45.95万
  • 项目类别:
Enhancing mammalian glycoprotein production in the baculovirus expression vector
增强杆状病毒表达载体中哺乳动物糖蛋白的产量
  • 批准号:
    8454713
  • 财政年份:
    2010
  • 资助金额:
    $ 45.95万
  • 项目类别:
Novel methods for improving virion production in baculovirus
提高杆状病毒病毒粒子产量的新方法
  • 批准号:
    7999941
  • 财政年份:
    2010
  • 资助金额:
    $ 45.95万
  • 项目类别:
Enhancing mammalian glycoprotein production in the baculovirus expression vector
增强杆状病毒表达载体中哺乳动物糖蛋白的产量
  • 批准号:
    8550085
  • 财政年份:
    2010
  • 资助金额:
    $ 45.95万
  • 项目类别:
Enhancing mammalian glycoprotein production in the baculovirus expression vector
增强杆状病毒表达载体中哺乳动物糖蛋白的产量
  • 批准号:
    7909460
  • 财政年份:
    2010
  • 资助金额:
    $ 45.95万
  • 项目类别:
Potent antimicrobial peptides from carrion beetles
来自腐肉甲虫的有效抗菌肽
  • 批准号:
    7671142
  • 财政年份:
    2009
  • 资助金额:
    $ 45.95万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.95万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 45.95万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 45.95万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了